SUPPLEMENTARY DATA. Supplementary Figure 1. PubMed
|
|
|
- Corey Dixon
- 5 years ago
- Views:
Transcription
1 Supplementary Figure 1. PubMed ((((((type 2 diabetes[title/abstract] OR type II diabetes[title/abstract] OR non-insulin diabetes[title/abstract]) AND (monounsaturated[title/abstract] OR polyunsaturated[title/abstract] OR fat[title/abstract] OR fatty acid[title/abstract] OR MUFA[Title/Abstract] OR PUFA[Title/Abstract] OR omega-6[title/abstract] OR n-6[title/abstract])) AND (glycemic[title/abstract] OR glucose[title/abstract] OR hba1c[title/abstract] OR lipid[title/abstract] OR cholesterol[title/abstract])) NOT (exercise[title/abstract] OR physical activity[title/abstract] OR metformin[title/abstract] OR acarbose[title/abstract] OR pioglitazone[title/abstract] OR rosiglitazone[title/abstract] OR sitagliptin[title/abstract] OR bi-guanide[title/abstract] OR troglitazone[title/abstract] OR fish oils[title/abstract] OR omega-3[title/abstract] OR n- 3[Title/Abstract] OR marine[title/abstract] OR simvastatin[title/abstract] OR pravastatin[title/abstract] OR supplements[title/abstract])) NOT (children[title/abstract] OR adolescent[title/abstract])) NOT (type 1 diabetes[title/abstract] OR type I diabetes[title/abstract] OR impaired glucose tolerance[title/abstract] OR prediabetes[title/abstract])) AND (trial[title/abstract] OR randomized[title/abstract]) AND (Clinical Trial[ptyp] AND hasabstract[text] AND ("0001/01/01"[PDAT] : "2015/03/31"[PDAT]) AND "humans"[mesh Terms] AND English[lang]) AND (Clinical Trial[ptyp] AND hasabstract[text] AND ("0001/01/01"[PDAT] : "2015/03/31"[PDAT]) AND "humans"[mesh Terms] AND English[lang]) Records found: 220
2 Supplementary Table 1. Inclusion/exclusion criteria for literature search
3 Supplementary Table 2. Assessment of publication bias CI: confidence interval; HbA1c: glycated hemoglobin; LDL: low-density lipoprotein; HDL: highdensity lipoprotein Bolded values indicate statistical significance at P < Notes: [1] P -value calculated from the Begg-Mazudumar test for assessing small effect size. [2] P-value calculated from the Egger test for assessing small effect size.
4 Supplementary Figure 2. Forest plots of main outcomes using random-effects model HbA1c (%)
5 Fasting plasma glucose (mmol/l)
6 Triglycerides (mmol/l)
7 Body weight (kg) Study ID WMD (95% CI) % Weight MUFA vs. CHO Garg 1988 (High-MUFA vs. High-CHO) Garg 1992 (High-MUFA vs. High-CHO) Parillo 1992 (High-MUFA vs. High-CHO) Lerman-Garber 1994 (High-MUFA vs. High-CHO) Campbell 1994 (High-MUFA vs. High-CHO) McCargar 1998 (High-MUFA vs. High-CHO) Rodriguez-Villar 2000 (MUFA vs. CHO) Tsihlias 2000 (MUFA vs. High-GI CHO) Tsihlias 2000 (MUFA vs. Low-GI CHO) Rodriguez-Villar 2004 (MUFA vs. CHO) Gerhard 2004 (High-MUFA vs. low-fat) Brunerova 2007 (MUFA vs. CHO) Wolever 2008 (MUFA vs. high-gi) Wolever 2008 (MUFA vs. low-gi) Esposito 2009 (Med vs. low-fat) Brehm 2009 (High-MUFA vs. High-CHO) Elhayany 2010 (Low-CHO Med vs. ADA) Elhayany 2010 (Traditional Med vs. ADA) Lasa 2014 (Olive oil vs. low fat) Lasa 2014 (Nuts vs. low fat) Subtotal (I-squared = 0.0%, p = 1.000). MUFA vs. PUFA Brynes 2000 (MUFA vs. PUFA) Subtotal (I-squared =.%, p =.). Overall (I-squared = 0.0%, p = 1.000) (-10.64, 10.44) 0.20 (-11.31, 11.71) (-10.50, 10.10) (-9.00, 7.00) 0.00 (-11.64, 11.64) (-10.77, 10.37) (-8.52, 7.52) (-8.15, 7.66) (-10.68, 4.33) (-8.54, 7.94) 1.20 (-14.39, 16.79) (-18.67, 2.67) 0.00 (-7.07, 7.07) 0.40 (-6.67, 7.47) (-4.41, 1.01) 1.40 (-5.67, 8.47) (-7.19, 2.39) (-6.36, 2.16) (-5.98, 1.38) (-6.42, 1.82) (-2.89, -0.23) 0.30 (-13.28, 13.88) 0.30 (-13.28, 13.88) (-2.87, -0.21) NOTE: Weights are from random effects analysis
8 Fasting insulin (pmol/l)
9 Systolic blood pressure (mmhg)
10 LDL cholesterol (mmol/l)
11 Diastolic blood pressure (mmhg)
12
13 Supplementary Figure 3. Funnel plots of main outcomes using random-effects model
14
15
16 Supplementary Table 3. Assessment of study quality
17
18
19
20 Supplementary Table 4. Baseline and outcome results for participants at the end of follow-up
21
22
23
24 Supplementary Table 5. Sensitivity analyses of high-mufa vs. high-cho diets in type 2 diabetes patients, after excluding trials resulting in significant weight differences CI: confidence interval; HbA1c: glycated hemoglobin; HDL: high-density lipoprotein; LDL: low-density lipoprotein; WMD: weighted mean difference Bolded values indicate statistical significance at P < Notes: [1] Calculated using a fixed-effects model. [2] Calculated using a random-effects model.
25 Supplementary Table 6. Sensitivity analyses of high-mufa vs. high-cho diets in type 2 diabetes patients, after excluding trials with less than 12 weeks duration CI: confidence interval; HbA1c: glycated hemoglobin; HDL: high-density lipoprotein; LDL: low-density lipoprotein; WMD: weighted mean difference Bolded values indicate statistical significance at P < Notes: [1] Calculated using a fixed-effects model. [2] Calculated using a random-effects model.
26 Supplementary Table 7. Food patterns in published studies
27 NS: not significant; NA: not available Bolded values indicate statistical significance at P < Notes: [1] For cross-over trials, the sample size is double the number of actual participants, since each participant received both interventions.
Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins
Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins Muller H, Jordal O, et al. (998) Replacement of partially hydrogenated soybean
Table S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group
Table S1: Nutrient composition of cracker and almond snacks Cracker* Almond** Weight, g 77.5 g (5 sheets) 56.7 g (2 oz.) Energy, kcal 338 364 Carbohydrate, g (kcal) 62.5 12.6 Dietary fiber, g 2.5 8.1 Protein,
SITA 100 mg (n = 378)
Supplementary Table 1. Summary of Sulfonylurea Background Therapy at Baseline and During the Treatment Period. Sulfonylurea at baseline, n (%) SITA 100 mg (n = 378) CANA 300 mg (n = 377) Total (N = 755)
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
Deprivation Study. The Freiburg Study
The Freiburg Study Deprivation Study Free Radicals Inflammation (hs-crp) Blood Pressure (Systolic, Diastolic) Blood Lipids (Cholesterol, Triglycerides) Energy Utilization (Heart Rate) Sugar Metabolism
Supplementary Table 1. Patient demographics and baseline characteristics (treated patients).
Supplementary Table 1. Patient demographics and baseline characteristics (treated patients). Placebo (n=188) 10 mg (n=186) 25 mg (n=189) Total (n=563) Gender, n (%) Male 75 (40) 97 (52) 84 (44) 256 (45)
Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
My Blood Value Responses to Diet and other Activities
My Blood Value Responses to Diet and other Activities Ben Best Pharmacy (BSc Pharm) Physics/Computing Science (BSc) 1 FreeStyle Lite to measure blood glucose n Values in mg/dl n [milligrams per tenth of
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±
Supplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
SCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
Proven and Proposed Cardiovascular Benefits of Soyfoods
Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com Alpro Foundation 20 years symposium
Medical Nutrition Therapy (MNT) for Diabetes Evidence based Recommendations
Medical Nutrition Therapy (MNT) for Diabetes Evidence based Recommendations Sarah Kim, MD Assistant Clinical Professor, UCSF SFGH No financial disclosures 1 Uses of MNT in diabetes To treat obesity and
NCBA Ground Beef Diet/Health Study
NCBA Ground Beef Diet/Health Study Stephen B. Smith Department of Animal Science Rosemary L. Walzem Department of Poultry Science Texas A&M University Assumptions: Corn-fed beef is healthier than pasture-fed
Supplementary Online Content
Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.
Nutritional Recommendations for the Diabetes Managements
In the name of God Nutritional for the Diabetes Managements Zohreh Mazloom. PhD Shiraz University of Medical Sciences School of Nutrition and Food Sciences Department of Clinical Nutrition OVERVIEW Healthful
Supplementary Online Content
Supplementary Online Content Afkarian M, Zelnick L, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. doi:10.1001/jama.2016.10924 emethods efigure
ANSC/NUTR) 618 LIPIDS & LIPID METABOLISM Dietary fat and Cardiovascular Disease
ANSC/NUTR) 618 LIPIDS & LIPID METABOLISM Dietary fat and Cardiovascular Disease I. Investigations in humans relating dietary fat intake to serum cholesterol A. Ansel Keys: the Keys Formula Cholesterol
Cleveland Clinic Heart Health Survey
Cleveland Clinic Heart Health Survey Table of Contents Section Slide # Survey Objectives and Methodology 3 Key Findings Part 1: Perceived Heart Health Knowledge 4 Key Findings Part 2: Heart Health Related
!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants
Aggregate Report Fasting Biometric Screening CLIENTXXXX May 2, 2014 21,000 participants Contact:404.636.9437~Website:www.atlantahealthsys.com RISK FACTOR QUESTIONNAIRE Participants Percent Do not exercise
Supplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: in people treated for type 2 diabetes with multiple daily insulin
Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
Facts on Fats. Ronald P. Mensink
Facts on Fats Ronald P. Mensink Department of Human Biology NUTRIM, School for Nutrition, Toxicology and Metabolism Maastricht University Maastricht The Netherlands Outline of the Presentation Saturated
Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
Nature Medicine: doi: /nm.3891
Supplementary Figure 1. Subjective responses. Thermal sensation, thermal comfort and self-reported shivering, determined at several time points (from t = min until t = 36 min) after entering the cold room,
Objectives. Medical Nutrition Therapy (MNT) for Diabetes Evidence-based Recommendations. No financial disclosures
Medical Nutrition Therapy (MNT) for Diabetes Evidence-based Recommendations Advances in Internal Medicine 2013 Sarah Kim, MD Assistant Clinical Professor, UCSF-SFGH No financial disclosures Objectives
FAT. Dr. Shamsul Azahari Zainal Badari Department of Resource Management and Consumer Studies Faculty of Human Ecology
FAT Dr. Shamsul Azahari Zainal Badari Department of Resource Management and Consumer Studies Faculty of Human Ecology OBJECTIVES LECTURE By the end of this lecture, student can: Define what is lipid/fat
J Pharm Pharm Sci ( 17(4) , 2014
Influence of Ascorbic Acid Supplementation on Type 2 Diabetes Mellitus in Observational and Randomized Controlled Trials; A Systematic Review with Meta-Analysis Ozra Tabatabaei-Malazy a,b, Shekoufeh Nikfar
Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,
Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator
Maintain Cholesterol
Maintain Cholesterol What is Cholesterol? Cholesterol is a Lipid Molecule that has a waxy appearance and is found in every cell of the body and has some important natural functions. It is manufactured
Traditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( )
Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com 1000 80 20 60 40 40 60 20 80
4. resisted training ** OR resistance training * OR resisted exercise ** OR resistance exercise ** OR strength training ** OR strength exercise **
Supplementary Table 1. Search strategy (up to January 10 th 2015). MEDLINE Result: 253 studies 1. clinical trial ** OR controlled trial ** OR randomized controlled trial * OR randomised controlled trial
High intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes
High intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes Sophie Cassidy, s.cassidy@ncl.ac.uk 1) Concentric remodelling 1.2 * Eccentricity ratio
Appendix 1: Systematic Review Protocol [posted as supplied by author]
![Appendix 1: Systematic Review Protocol [posted as supplied by author]](/thumbs/88/115654209.jpg "Appendix 1: Systematic Review Protocol [posted as supplied by author]")
Appendix 1: Systematic Review Protocol [posted as supplied by author] Title Physical Activity and Risks of Breast Cancer, Colon Cancer,, Ischemic Heart Disease and Ischemic Stroke Events: A Systematic
International Food Information Council Foundation
International Food Information Council Foundation A New Nutrition Conversation with Consumers about Fats in Food Continuing Professional Education Self-Study Module CPE QUESTIONS with ANSWERS 1. Since
Pattern of lipid biomarkers and risk of cardiovascular disease
Pattern of lipid biomarkers and risk of cardiovascular disease Robert Clarke Clinical Trial Service Unit University of Oxford 9 January 2017 Biomarkers for dietary fats Blood lipids (LDL, HDL, triglycerides,
(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
Cardiovascular risk potential of dietary saturated fats: an update and some implications
Cardiovascular risk potential of dietary saturated fats: an update and some implications Gerard Hornstra, PhD Med" Prof. Em. of Experimental Nutrition" Maastricht University" The Netherlands" Cardiovascular
EPOA. Latest Insights on Palm Oil & Health. European Industry Meeting on Palm Oil Nicolette Drieduite I EPOA Project team member I Cargill 2 June 2015
EPOA Latest Insights on Palm Oil & Health European Industry Meeting on Palm Oil Nicolette Drieduite I EPOA Project team member I Cargill 2 June 2015 Summary 1. In the nineties palm oil s success was related
NOTES. Developed by Fabio Comana, MA., MS., All rights Reserved Page 1
Session 455: Core Essentials in Science Fabio Comana, MA, MS, NASM CPT, CES & PES; ACE CPT & LWMC; ACSM HFS, NSCA CSCS; CISSN National Academy of Sports Medicine fabio.comana@nasm.org NOTES Developed by
External Examiner: Miss C Biggs Internal Examiner: Mrs S Ogilvie DURATION: 3 HOURS TOTAL MARKS: 150
External Examiner: Miss C Biggs Internal Examiner: Mrs S Ogilvie DURATION: 3 HOURS TOTAL MARKS: 150 NOTE THIS PAPER CONSISTS OF SEVEN (7) PAGES AND APPENDIX A ONE (1) PAGE AND APPENDIX B ONE (1) PAGE PLEASE
Understanding the metabolic syndrome
Understanding the metabolic syndrome Understanding the metabolic system Metabolic syndrome is the clustering together of a number of risk factors for heart disease, stroke and diabetes. Having one of these
Metabolic Syndrome.
www.bmiweightloss.com.au What is the metabolic syndrome? The was first described in 1988 by Gerald Reavson It was originally described as the clustering of four conditions These conditions when present
Supplementary Online Content
Supplementary Online Content Engebretson SP, Hyman LG, Michalowicz BS, et al. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels among persons with type 2 diabetes and chronic periodontitis:
(A) (B) 2019 American Diabetes Association. Published online at
Supplementary Figure S1. Risk of bias for all included trials Studies were rated Low Risk of Bias if the study design is unlikely to have little influence over the true outcome; High Risk of Bias if the
The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences
The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences What should we be promoting? Define health benefits in terms
Supplementary Online Content
Supplementary Online Content Anagnostou E, Aman MG, Handen BL, et al. Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autistic spectrum disorder:
SUPPLEMENTARY DATA. Supplementary Table S1. Clinical characteristics of the study subjects.*
Supplementary Table S1. Clinical characteristics of the study subjects.* T2D ND n (F/M) 66 (21/45) 25 (7/18) Age (years) 61.8 ± 6.9 49.4 ± 7.3 # Body weight (kg) 95 ± 16 105 ± 13 # Body mass index (kg.
STUDY QUESTIONS, Chapter 5: The Lipids: Fats, Oils, Phospholipids and Sterols
STUDY QUESTIONS, Chapter 5: The Lipids: Fats, Oils, Phospholipids and Sterols To answer the next questions, read the introductory paragraphs, Introducing the Lipids and A Close Look at Lipids in Ch. 5.
Macronutrients and Dietary Patterns for Glucose Control
제 20 회대한당뇨병학회춘계학술대회 Macronutrients and Dietary Patterns for Glucose Control 2017.5.13 서울대학교병원임정현 Conflict of interest disclosure None Committee of Scientific Affairs Contents Review of Nutrition Recommendation
Insert logo. Linda Main, Dietetic Adviser
Insert logo Linda Main, Dietetic Adviser HEART UK The Cholesterol Charity Our Vision: To prevent avoidable and early deaths caused by high cholesterol. We want the majority of UK adults to know their cholesterol
SUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics
Supplementary Table 1. Baseline Patient Characteristics Normally distributed data are presented as mean (±SD), data that were not of a normal distribution are presented as median (ICR). The baseline characteristics
Principles of Management. Dietary Management of Diabetes mellitus. Goals with dietary intervention. Dietary management. Atkins diet (Low CHO)
Dietary Management of Diabetes mellitus Principles of Management Diabetes mellitus Marlene Gilfillan Medical treatment Exercise Diet Goals with dietary intervention Decrease HbA1c Losing weight Balancing
Lipids do not like water! (aka: hydrophobic) Generally insoluble
Lipids Lipids Lipids do not like water! (aka: hydrophobic) Generally insoluble Lipids They act like this because of their molecular structure (non-polar) Lipids are made mostly of C and H atoms, with O
Diabetes OR T2D$ OR NIDDM OR MODY OR Non-insulin dependent OR Insulin OR IDDM OR Poorly-controlled
Appendix 1: Search String Pubmed/ Medline Diabetes OR T2D$ OR NIDDM OR MODY OR Non-insulin dependent OR Insulin OR IDDM OR Poorly-controlled Lipid OR cholesterol OR blood pressure OR hypertension OR cardiovascular
Assignment Lesson Plan: Healthy and Unhealthy Fats
Assignment Lesson Plan: Healthy and Unhealthy Fats Duration: 35 minutes Target Group: College students around the ages of 18 to 22 years old. Overall Goal: To increase knowledge of what healthy fats and
Weight Loss NOTES. [Diploma in Weight Loss]
![Weight Loss NOTES. [Diploma in Weight Loss]](/thumbs/82/86567947.jpg "Weight Loss NOTES. [Diploma in Weight Loss]")
Weight Loss NOTES [Diploma in Weight Loss] Fat s: The good, the bad and the ugly Fat s function in your body 1. Energy stores 2. Muscle fuel 3. Transportation 4. Cell membrane 5. Padding 6. Muscle fuel
The Role of Monounsaturated Fatty Acids in Cardiovascular Disease. and Diabetes Mellitus Type 2. By Jovan Duvall. May 21 st 2012 NUTR 420
Duvall 1 The Role of Monounsaturated Fatty Acids in Cardiovascular Disease and Diabetes Mellitus Type 2 By Jovan Duvall May 21 st 2012 NUTR 420 Duvall 2 Introduction American s waistbands are not the only
Pasta: A High-Quality Carbohydrate Food
Pasta: A High-Quality Carbohydrate Food Cyril W.C. Kendall Department of Nutritional Sciences, Faculty of Medicine, University of Toronto; Clinical Nutrition & Risk Factor Modification Center, St. Michael
Bariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes
The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,
DIABETES GLOBAL SCENARIO. About 347 million people worldwide have diabetes
DIABETES GLOBAL SCENARIO About 347 million people worldwide have diabetes There is an emerging global epidemic of diabetes that can be traced back to rapid increases in overweight, obesity and physical
Gender: M Chart No: Fasting: Yes. Boston Heart HDL Map TM Test 1 ApoA-I (mg/dl) levels in HDL particles. α Range > <14 mg/dl. α-2 50.
Pro vider: Ordering Provider 123 Main Street Anytown, ST 12345 Account No: DOB: 00/00/1950 Framingham Risk Score: Patient Info: FAMILY HIST CVD Lipid, Lipoprotein and Apolipoprotein Tests Total Cholesterol
Understanding Cholesterol and Triglycerides
MINTO PREVENTION & REHABILITATION CENTRE CENTRE DE PREVENTION ET DE READAPTATION MINTO Understanding Cholesterol and Triglycerides About This Kit Along with cigarette smoking, high blood pressure, physical
Supplementary Online Content
Supplementary Online Content Sigal RJ, Alberga AS, Goldfield GS, et al. Effects of aerobic training, resistance training, or both on percentage body fat and cardiometabolic risk markers in obese adolescents:
Fats, Cholesterol, and Hormones
Fats, Cholesterol, and Hormones 1 Types of Fats Lipids biological origin sparingly soluble in water Main classes of lipids Fatty Acids long hydrocarbon chains with a carboxylic acid on one end Triacylglycerols
Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use
Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Baseline characteristics Users (n = 28) Non-users (n = 32) P value Age (years) 67.8 (9.4) 68.4 (8.5)
Supplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Ray K K, Seshasai S R K, Wijesuriya S,
Clinical Care Performance. Financial Year 2012 to 2018
Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c
Saturated fat- how long can you go/how low should you go?
Saturated fat- how long can you go/how low should you go? Peter Clifton Baker IDI Heart and Diabetes Institute Page 1: Baker IDI Page 2: Baker IDI Page 3: Baker IDI FIGURE 1. Predicted changes ({Delta})
Medical Nutrition Therapy Options for Adults Living with Diabetes. Jane Eyre Schuster, RD, LD, CDE Legacy Health Diabetes and Nutrition Services
Medical Nutrition Therapy Options for Adults Living with Diabetes Jane Eyre Schuster, RD, LD, CDE Legacy Health Diabetes and Nutrition Services Objectives Discuss Medical Nutrition Therapy considerations
SUPPLEMENTARY MATERIAL
SUPPLEMENTARY MATERIAL The effect of current dietary provided by frequent advice versus food delivery on weight loss and cardiovascular risk factors. A Randomized Clinical Trial. David JA Jenkins, Beatrice
Supplementary Online Content
Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.
Some Interesting Nutritional Biochemistry of Sugars
Some Interesting Nutritional Biochemistry of Sugars 1 The Fructose Paradox: Sweet Poison Very sweet sugar Cheap to produce (high fructose corn syrup) Low Glycemic Index.but, it s a nutritional nightmare!
Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
Clinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
Reduction in saturated fat intake for cardiovascular disease(review)
Cochrane Database of Systematic Reviews Reduction in saturated fat intake for cardiovascular disease (Review) HooperL,MartinN,AbdelhamidA,DaveySmithG HooperL,MartinN,AbdelhamidA,DaveySmithG. Reduction
2013 Hypertension Measure Group Patient Visit Form
Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part
Supplementary Note Details of the patient populations studied Strengths and weakness of the study
Supplementary Note Details of the patient populations studied TVD and NCA patients. Patients were recruited to the TVD (triple vessel disease) group who had significant coronary artery disease (defined
Mediterranean Diet is an Effective Method for Treating Type 2 Diabetes in Adults
Sacred Heart University DigitalCommons@SHU Health Sciences Undergraduate Publications Health Sciences 12-2013 Mediterranean Diet is an Effective Method for Treating Type 2 Diabetes in Adults Amy Bois Sacred
Impact of trans fats on health EFSA s work related to trans Fatty acids
Setting the scene Impact of trans fats on health EFSA s work related to trans Fatty acids Prof. Ambroise Martin Member of the EFSA WG on DRVs (former chair 2006-2015) and NDA Panel 2006-2015 (former chair
Session 21: Heart Health
Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk
American Diabetes Association: Standards of Medical Care in Diabetes 2015
American Diabetes Association: Standards of Medical Care in Diabetes 2015 Synopsis of ADA standards relevant to the 11 th Scope of Work under Task B.2 ASSESSMENT OF GLYCEMIC CONTROL Recommendations: Perform
Lipids, pt. 1. Feb. 3, Bio 28: Nutrition Instructor: Paul Nagami Laney College
Lipids, pt. 1 Feb. 3, 2014 Bio 28: Nutrition Instructor: Paul Nagami Laney College Today s Agenda Reminders + Administrative Details What Are Lipids? Chemistry and Types of Lipids Fatty Acids Saturated
What should I eat? I am so confused. Jennifer Lyon DO
What should I eat? I am so confused. Jennifer Lyon DO Conflict of Interest Disclosure I have no conflict of interest to report Overview 2015-2020 Dietary Guidelines 5 primary guidelines Sugar intake Sodium
Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
Low carbohydrate diets- do they have a place?
Low carbohydrate diets- do they have a place? Grant Schofield Professor of Public Health AUT University, Auckland NZ @grantsnz www.facebook.com/profgrant www.profgrant.com Atherogenic dyslipidemia is [primarily]
Bulletin Board Packet
Bulletin Board Packet Eat for the Health of It! Nutrition Description: This bulletin board packet includes information on the topic of nutrition. MyPlate is a reminder to find your healthy eating style
2.3 Carbon-Based Molecules. KEY CONCEPT Carbon-based molecules are the foundation of life.
KEY CONCEPT Carbon-based molecules are the foundation of life. Carbon atoms have unique bonding properties. Carbon forms covalent bonds with up to four other atoms, including other carbon atoms. Carbon-based
Diabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?
Retinopathy Diabetes has a negative effect on eyes in many ways, increasing the risk of cataracts for example, but the most common and serious ocular complication of diabetes is retinopathy. Diabetic retinopathy
Diabetes and New Meds for Cardiovascular Risk Reduction. F. Dwight Chrisman, MD, FACC. Disclosures: BI Boehringer Ingelheim speaker
Diabetes and New Meds for Cardiovascular Risk Reduction F. Dwight Chrisman, MD, FACC Disclosures: BI Boehringer Ingelheim speaker 1 Prevalence of DM DM state specific prevalence 2006 4%-6% 6-8% 8-10% 10-12%
Professor Clare Collins
Dietary Patterns and Cardiovascular Disease (CVD) Outcomes: An evidence summary Professor Clare Collins PhD, BSc, Dip Nutr&Diet, Dip Clin Epi, advapd, FDAA Director of Research, School of Health Sciences,
Exercise for type 2 diabetes mellitus (Review)
Thomas DE, Elliott EJ, Naughton GA This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2007, Issue 1 http://www.thecochranelibrary.com
2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD
2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD How do you interpret my blood test results? What are our targets for these tests? Before the ACC/AHA Lipid Guidelines A1c:
Know Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
Dr Anne King dc life dclife.co.uk
The Vampire Strikes Back Dr Anne King dc life dclife.co.uk Overview Clinical -v- Underwriting Blood physiology The blood sample Screening for the 3 main killers The top 3 useful blood tests The future
Nutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source
Tools: Printer 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut along dashed lines Copyright Goodheart-Willcox Co., Inc. All rights reserved. Tissue in which the body
GRADE Evidence Profiles on Long- and Rapid-Acting Insulin Analogues for the treatment of Diabetes Mellitus [DRAFT] October 2007
![GRADE Evidence Profiles on Long- and Rapid-Acting Insulin Analogues for the treatment of Diabetes Mellitus [DRAFT] October 2007](/thumbs/84/90988922.jpg "GRADE Evidence Profiles on Long- and Rapid-Acting Insulin Analogues for the treatment of Diabetes Mellitus [DRAFT] October 2007")
GRADE Evidence Profiles on Long- and Rapid-Acting Insulin Analogues for the treatment of Diabetes Mellitus October 2007 Canadian Agency for Drugs and Technologies in Health Disclaimer This report is prepared
Nature Genetics: doi: /ng.3561
Supplementary Figure 1 Pedigrees of families with APOB p.gln725* mutation and APOB p.gly1829glufs8 mutation (a,b) Pedigrees of families with APOB p.gln725* mutation. (c) Pedigree of family with APOB p.gly1829glufs8